摘要:
An operator network is capable of routing incoming customer care calls to specific customer care representatives based on a subscriber profile and customer service representative (CSR) skill set. The device profile is retrieved from the mobile handset while the incoming customer care call is in a queue waiting to be connected to a CSR. The retrieved device profile is also used to determine an appropriate CSR to handle an incoming customer care call.
摘要:
Methods are provided in which electronic devices are distributed while systems are maintained for conducting transactions with the electronic devices across a network. Each electronic device includes a unique device identification, and across the network a database stores an amount of credit in association with each unique device identification. To conduct a transaction, the electronic device establishes a connection over the network to a network location that can access the database. The network location receives the device identification from the electronic device and uses the device identification to determine the amount of stored credit from the database. A user of the electronic device can then exchange stored credit for goods and/or services, transfer credits to others, and purchase additional credits.
摘要:
A scale inhibition method comprising: (a) injecting a dispersion of seed particles of an insoluble mineral salt in an aqueous medium into a formation through an injection well wherein the seed particles have an equivalent spherical diameter of 100% less than 100 nm, preferably 100% less than 50 nm, more preferably 100% less than 25 nm and the aqueous medium has dissolved therein precipitate precursor ions that form a precipitate of the insoluble mineral salt when contacted with resident ions in the formation; (b) allowing the dispersion to percolate through the subterranean formation towards production well and producing the dispersion from the production well; and (c) controllably precipitating the insoluble mineral salt onto the seed particles so as to reduce the deposition of the insoluble mineral salt onto the walls of the porous formation and/or onto the surface in the production well and/or onto the surface downstream of the production well.
摘要:
An optical disc having a read-only portion and a writable portion is provided. The read-only portion comprises computer-readable instructions including a backup application. When the optical disc is inserted into an optical drive of a data source, such as a personal computer, the operating system of the data source automatically launches the backup application. The backup application is configured to find files on the data source that satisfy search criteria, which can be predefined, and to copy those files to the writable portion of the optical disc.
摘要:
Compounds of formula I: are potent inhibitors of gamma-secretase and hence find use in treatment or prevention of diseases associated with deposition of β-amyloid.
摘要:
A method of treating a subterranean formation, the method comprising: (A) injecting down a well bore into the formation an admixture of (a) an emulsion having an internal aqueous phase comprising a water-soluble oil or gas field chemical or an aqueous dispersion of a water-dispersible oil or gas field chemical and an external oil phase comprising a liquid hydrocarbon and an oil-soluble surfactant and (b) a demulsifier comprising a solution of a surfactant having a cloud point temperature of above 40° C.; or (B) separately injecting down a well bore into the formation emulsion (a) and demulsifier (b) and generating an admixture of emulsion (a) and demulsifier (b) within the formation.
摘要:
Compounds of formula 1: wherein X represents a 5-(R-substituted)-1,2,4-oxadiazole-3-yl moiety are inhibitors of gamma-secretase, and hence useful for treating Alzheimer's disease.
摘要:
Compounds of the general formula (I): ##STR1## in which one or more substituents R.sub.1 may be present and in which: R.sub.1 represents a halogen atom, preferably fluorine or chlorine, or a trifluoromethyl group or a group --NR.sub.5 R.sub.6 in which R.sub.5 and R.sub.6 which may be the same or different represent a hydrogen atom, or an alkyl group containing from 1 to 6 carbon atoms, preferably 1 to 4 carbon atoms or an acyl group, preferably the residue of a C.sub.1 -C.sub.6 alkanoic acid;X represents a straight or branched chain alkyl group containing 2 to 6 carbon atoms; andR.sub.2 and R.sub.3 which may be the same or different each represent a hydrogen atom or an alkyl group containing from 1 to 4 carbon atoms, preferably a methyl group; andR.sub.4 represents a hydrogen atom or an alkyl group containing 1 to 4 carbon atoms, are provided together with processes for the production thereof. They have a .beta..sub.2 -stimulant activity.
摘要:
The present invention provides a compound of the following formula and salts thereof: Also provided is the use of these compounds as antibacterials, compositions comprising them and processes for their manufacture.
摘要:
The invention provides a combination comprising an ancillary compound (e.g. one, two or more ancillary compounds) and a compound of the formula (I) having protein kinase B inhibiting activity: wherein A is a saturated hydrocarbon linker group containing from 1 to 7 carbon atoms, the linker group having a maximum chain length of 5 atoms extending between R1 and NR2R3 and a maximum chain length of 4 atoms extending between E and NR2R3, wherein one of the carbon atoms in the linker group may optionally be replaced by an oxygen or nitrogen atom; and wherein the carbon atoms of the linker group A may optionally bear one or more substituents selected from oxo, fluorine and hydroxy, provided that the hydroxy group when present is not located at a carbon atom α with respect to the NR2R3 group and provided that the oxo group when present is located at a carbon atom α with respect to the NR2R3 group; E is a monocyclic or bicyclic carbocyclic or heterocyclic group; R1 is an aryl or heteroaryl group; and R2, R3, R4 and R5 are as defined in the claims. Also provided are patient packs, pharmaceutical kits and packs and compositions containing the combinations, methods for preparing the combinations and their use in combination therapy as anticancer agents.
摘要翻译:本发明提供包含辅助化合物(例如一种,两种或多种辅助化合物)和具有蛋白激酶B抑制活性的式(I)化合物的组合的组合:其中A是含有1至7个碳原子的饱和烃连接基团 ,连接基团具有在R1和NR2R3之间延伸的5个原子的最大链长度,以及在E和NR 2 R 3之间延伸的4个原子的最大链长度,其中连接基团中的一个碳原子可以任选被氧或氮取代 原子; 并且其中连接基团A的碳原子可以任选地具有一个或多个选自氧代,氟和羟基的取代基,条件是当存在的羟基不相对于NR 2 R 3基团位于碳原子α时,条件是 存在时的氧代基位于相对于NR 2 R 3基团的碳原子α; E是单环或双环碳环或杂环基; R1是芳基或杂芳基; 并且R 2,R 3,R 4和R 5如权利要求中所定义。 还提供了包含组合的患者包装,药物盒和包装和组合,用于制备组合的方法及其在联合治疗中作为抗癌剂的用途。